secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2021-12-06T23:59:59+00:00
Accession:  0001140361-21-040395
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences completes acquisition of Cernostics for $30M upfront cash, up to $50M earnout
--------------------------------------------------------------------------------

- Acquisition closed December 3, 2021; upfront cash consideration approximately $30 million.
- Up to $50 million additional earnout payable in cash or stock upon achieving 2022 commercial milestones.
- Merger agreement amended to cap stock issuance at 19.9% of outstanding shares for Nasdaq compliance.
- Cernostics becomes wholly owned subsidiary; post-closing adjustments and escrow apply.
- Financial statements of acquired business to be filed by amendment within 71 calendar days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000114036121040395/0001140361-21-040395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000114036121040395/brhc10031497_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-040395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer